16th Annual ESH-iCMLF International Conference on CML – Biology and Therapy

Activity: Other


White DL, Saunders VA, Eadie LN, Yeung, D, Hughes TP.
The depth of in vivo kinase inhibition achieved over the first month of nilotinib therapy predicts for subsequent molecular response and is closely related to nilotinib plasma levels.
Oral Presentation
Estoril, Portugal
Period26 Sep 201329 Sep 2013